| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/27/2006 | US20060167229 Biologically active peptide conjugates |
| 07/27/2006 | US20060167228 Sequences from an endosymbiont and their uses |
| 07/27/2006 | US20060167227 Truncated tau proteins |
| 07/27/2006 | US20060167226 Mutations of voltage-gated ion channnels that allow them to express a voltage-independent phenotype and an improved method to use the same |
| 07/27/2006 | US20060167225 Novel fluorescent protein from aequorea coerulscens and methods for using the same |
| 07/27/2006 | US20060166924 Gene therapeutics |
| 07/27/2006 | US20060166921 RNAi modulation of RSV and therapeutic uses thereof |
| 07/27/2006 | US20060166918 chemically modified oligonucleotides; double stranded iRNA agent; comprising a cholesterol moiety; increased stability in a biological sample |
| 07/27/2006 | US20060166917 Differentiation and/or proliferation modulating agents and uses therefor |
| 07/27/2006 | US20060166914 Method of nucleic acid infusion |
| 07/27/2006 | US20060166913 Process for producing sirna |
| 07/27/2006 | US20060166910 Rna-interference by single-stranded rna molecules |
| 07/27/2006 | US20060166909 Oligonucleotide inhibitors of mbd2/dna demethylase and uses thereof |
| 07/27/2006 | US20060166889 Chimeric peptides that facilitate the transport of insulin across biological membranes that have a first domain having a specific translocation sequence and a second domain having at least a biologically active portion of an insulin polypeptide; treatment of diabetes |
| 07/27/2006 | US20060166888 for arachidonic acid release in target cells; intracellular calcium release; phospholipases |
| 07/27/2006 | US20060166876 Delocalization molecules and use thereof |
| 07/27/2006 | US20060166875 Single chain recombinant t cell receptors |
| 07/27/2006 | US20060166864 Methods for modulating telomerase activity |
| 07/27/2006 | US20060166377 Particle for magnetically induced membrane transport |
| 07/27/2006 | US20060166364 Use of flexible bag containers for viral production |
| 07/27/2006 | US20060166363 Modified baculovirus expression system for production of pseudotyped rAAV vector |
| 07/27/2006 | US20060166359 Transgenic mice containing lumulus clotting factor protease-like gene disruptions |
| 07/27/2006 | US20060166349 Recovery of plasmids in an aqueous two-phase system |
| 07/27/2006 | US20060166338 Alleles of the mqo gene from coryneform bacteria |
| 07/27/2006 | US20060166334 Method and compositions for rapidly modifying clones |
| 07/27/2006 | US20060166332 introducing linear DNA molecules into cells, then circularizing the DNA by joining them at an asymmetrical nucleotide sequences having the same or opposite orientation with respect to one another; genetic engineering |
| 07/27/2006 | US20060166331 Pharmaceutical grade manufacture of quality plasmid DNA from cell lysates using flotation to separate and eliminate undesired insoluble cellular debris including chromosomal DNA from the lysates |
| 07/27/2006 | US20060166325 Glial cell line-derived neurotrophic factor receptor |
| 07/27/2006 | US20060166323 Providing or maintaining the cell under non-inducing conditions, where the cell comprises at least one of the recombinant nucleic acid (promoters); controlling the transcription of nucleic acid |
| 07/27/2006 | US20060166322 Cellulases; beta-glucosidases; hydrolases; conversion of cellulose to sugars and/or ethanol; laundry detergents |
| 07/27/2006 | US20060166321 Recombinant influenza vectors with tandem transcription units |
| 07/27/2006 | US20060166320 In vitro expression of the HCV ARFP/F-core‘coding open reading frame |
| 07/27/2006 | US20060166319 Charging tRNA with pyrrolysine |
| 07/27/2006 | US20060166318 Methods, compositions, and cells for encapsidating recombinant vectors in AAV particles |
| 07/27/2006 | US20060166317 Nucleic acids encoding sialytransferases from C. jejuni |
| 07/27/2006 | US20060166315 Process for producing pnpase |
| 07/27/2006 | US20060166314 Method for rational mutagenesis of alpha/beta t-cell receptors and correspondingly mutated mdm2-protein specific alpha/beta t-cell ceceptores |
| 07/27/2006 | US20060166313 Novel glycero kinase, gene thereof and process for producing the glycerol kinase by using the gene |
| 07/27/2006 | US20060166311 Novel notch-origin polypeptides and biomarkers and reagents using the same |
| 07/27/2006 | US20060166309 Novel G-protein coupled receptors |
| 07/27/2006 | US20060166281 Tissue targeted therapy; identifying antitumor agents specific to transphosphorylase domain of c-kit; interleulin-3 cell targeting |
| 07/27/2006 | US20060166275 Amyloid beta protein (globular assembly and uses thereof) |
| 07/27/2006 | US20060166274 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 07/27/2006 | US20060166266 Screening method for regulatory enzymes employing tribrid (tri-hybrid) system |
| 07/27/2006 | US20060166263 Randomized libraries of zinc finger proteins |
| 07/27/2006 | US20060166260 Visualization of avian eggs |
| 07/27/2006 | US20060166259 APM1 biallelic markers and uses thereof |
| 07/27/2006 | US20060166258 Preservation of RNA in a biological sample |
| 07/27/2006 | US20060166257 Converting diploidy to haploidy for genetic diagnosis |
| 07/27/2006 | US20060166256 IL-1 receptor accessory protein |
| 07/27/2006 | US20060166255 Methods of using 48149, a human Aminopeptidase family member |
| 07/27/2006 | US20060166252 Novel methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteins |
| 07/27/2006 | US20060166246 Detection of fungal pathogens using the polymerase chain reaction |
| 07/27/2006 | US20060166237 Fluorescence correlation spectroscopy (FCS); detection result can be obtained in a short time without performing troublesome operation; detecting whether a binding site of a transcription factor TFIID and a transcription factor TFIIB is present in a labeled DNA |
| 07/27/2006 | US20060166234 Apparatus and system having dry control gene silencing compositions |
| 07/27/2006 | US20060166225 Methods and compositions for polypeptide engineering |
| 07/27/2006 | US20060166214 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker |
| 07/27/2006 | US20060166213 Novel compositions and methods in cancer |
| 07/27/2006 | US20060166211 Ss 1,3-n-acetyl-d-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same |
| 07/27/2006 | US20060166209 Growth hormone variations in humans and its uses |
| 07/27/2006 | US20060166206 Methods and compositions for analysis of regulatory sequences |
| 07/27/2006 | US20060166202 proteins comprising an amino acid sequence including the catalytic region and regulatory domains; the protein inhibits neurite retraction in an (lysophosphatidic acid) LPA-induced neurite retraction bioassay; used for treating nervous system disorders and/or injuries |
| 07/27/2006 | US20060166200 Compositions of solution for sequencing reaction clean-up |
| 07/27/2006 | US20060166199 Use of quality control probes that are synthesized on the microarray for assessing microarray quality; determining if a positionally-addressable biopolymer array has a synthesis defect |
| 07/27/2006 | US20060166198 Providing a first population of single-stranded polynucleotide molecules and a second population of single-stranded polynucleotide molecules, carrying out reaction for digesting, contacting polynucleotide fragments generated from plus strands with fragments generated from the minus strands, amplifying |
| 07/27/2006 | US20060166197 Building block capable of transferring a functional entity |
| 07/27/2006 | US20060166196 Reporter gene assay method |
| 07/27/2006 | US20060166194 Diagnosis and treatment of cancer |
| 07/27/2006 | US20060166193 Binding protein |
| 07/27/2006 | US20060166190 Magnetism based nucleic acid amplification |
| 07/27/2006 | US20060166188 Methods of examining swine genetic resistance to rna virus-origin disease |
| 07/27/2006 | US20060165805 Magnetic pole matrices useful for tissue engineering and treatment of disease |
| 07/27/2006 | US20060165770 Lipid particles having asymmetric lipid coating and method of preparing same |
| 07/27/2006 | US20060165768 Phosphoramide type cationic lipid compounds such as 3-[[bis(tetradecyloxy)phosphoryl](methyl)amino]-N,N,N-trimethyl-propanaminium iodide; use as nonviral vectors for gene transfer |
| 07/27/2006 | US20060165744 Combination liposomal formulations |
| 07/27/2006 | US20060165729 Protein from photobacterium damselae and use thereof |
| 07/27/2006 | US20060165728 Campylobacter glycans and glycopeptides |
| 07/27/2006 | US20060165727 Vaccine; inducing an immune response; infectious diseases, which can be caused by more than one strain, clade, variant, subtype or serotype of infectious disease causing microorganism; reliable vaccination against all Dengue virus serotypes |
| 07/27/2006 | US20060165726 Remedies with the use of hollow protein nanoparticles presenting growth factor or the like |
| 07/27/2006 | US20060165725 HBV drug resistance drug resistance detection methods |
| 07/27/2006 | US20060165724 Method of producing infectious reovirus |
| 07/27/2006 | US20060165723 Nucleic acid sequences encoding proteins capable of associating into a virus-like particle |
| 07/27/2006 | US20060165714 Peptides for vaccination against human CMV |
| 07/27/2006 | US20060165713 Vaccine |
| 07/27/2006 | US20060165707 Substances |
| 07/27/2006 | US20060165706 Antibodies against CTLA4 and uses therefor |
| 07/27/2006 | US20060165694 Fab fragments and their DNA sequences used for preparation of complete recombinant Anti-Rhesus D antibodies; biodrugs; medical diagnosis |
| 07/27/2006 | US20060165693 treating a patient having cancer |
| 07/27/2006 | US20060165692 Humanized anti-CD3 specific antibodies |
| 07/27/2006 | US20060165691 Humanized anti-CD3 specific antibodies |
| 07/27/2006 | US20060165689 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7 |
| 07/27/2006 | US20060165684 T-cell immune response cDNA 7 (TIRC7) antagonist; rheumatoid arthritis; comprising all three complementarity determining regions (CDRs) of the VH and all three complementarity determining regions (CDRs) of the VL variable regions; inhibiting proliferation of peripheral blood mononuclear cells |
| 07/27/2006 | US20060165681 Antibodies to myelin associated glycoprotein (MAG); neurological diseases/disorders |
| 07/27/2006 | US20060165678 Measuring changes in level of antigen recognizable by a monoclonal antibody or antigen binding fragment; monoclonal antibody is produced by hybridoma cell line; decreased level indicates a reduced tumor; diagnosis, cell purification |
| 07/27/2006 | US20060165668 Genetically modified tumor cells as cancer vaccines |
| 07/27/2006 | US20060165665 Immunomodulation using altered dendritic cells |
| 07/27/2006 | US20060165664 Method of inducing an enhanced immune response against hiv |
| 07/27/2006 | US20060165660 DNA preparation comprising a DNA, proteins and endotoxins; gene therapy; cystic fibrosis |
| 07/27/2006 | US20060165659 detecting a reduction in gene copy number, by determining gene mutational status, or by detecting a reduction in the RNA transcribed from these genes; inhibition of neoplastic or tumorigenic growth of cancers such as chronic lymphocytic leukemia or prostate cancer cells |
| 07/27/2006 | US20060165658 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |